Halozyme Therapeutics shares owned by Arrowpoint Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Arrowpoint Asset Management
from 13F filings
Historical chart of Arrowpoint Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Arrowpoint Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Arrowpoint Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $58M | 1.6M | 36.96 |
| 2023-09-30 | $58M | 1.5M | 38.20 |
| 2023-06-30 | $48M | 1.3M | 36.07 |
| 2023-03-31 | $44M | 1.2M | 38.19 |
| 2014-06-30 | $198k | 20k | 9.90 |
| 2014-03-31 | $446k | 35k | 12.72 |
| 2013-12-31 | $465k | 31k | 15.00 |
| 2013-09-30 | $185k | 17k | 11.04 |
More positions owned by Arrowpoint Asset Management
View all positions for Arrowpoint Asset Management